An open-label Phase I trial to evaluate the pharmacokine

Project: Research project

Description

An open-label Phase I trial to evaluate the pharmacokinetics and safety profile of BAY 94-9027 following single and multiple dose administration in two cohorts of previously treated male subjects with severe hemophilia A
StatusFinished
Effective start/end date6/1/105/31/13

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint

Hemophilia A
Pharmacokinetics
Safety
BAY 94-9027